Literature DB >> 20457615

Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates.

Laeticia Alibaud1, Anuradha Alahari, Xavier Trivelli, Anil K Ojha, Graham F Hatfull, Yann Guerardel, Laurent Kremer.   

Abstract

The cell envelope is a crucial determinant of virulence and drug resistance in Mycobacterium tuberculosis. Several features of pathogenesis and immunomodulation of host responses are attributable to the structural diversity in cell wall lipids, particularly in the mycolic acids. Structural modification of the alpha-mycolic acid by introduction of cyclopropane rings as catalyzed by the methyltransferase, PcaA, is essential for a lethal, persistent infection and the cording phenotype in M. tuberculosis. Here, we demonstrate the presence of cyclopropanated cell wall mycolates in the nonpathogenic strain Mycobacterium smegmatis and identify MSMEG_1351 as a gene encoding a PcaA homologue. Interestingly, alpha-mycolic acid cyclopropanation was inducible in cultures grown at 25 degrees C. The growth temperature modulation of the cyclopropanating activity was determined by high resolution magic angle spinning NMR analyses on whole cells. In parallel, quantitative reverse transcription-PCR analysis showed that MSMEG_1351 gene expression is up-regulated at 25 degrees C compared with 37 degrees C. An MSMEG_1351 knock-out strain of M. smegmatis, generated by recombineering, exhibited a deficiency in cyclopropanation of alpha-mycolates. The functional equivalence of PcaA and MSMEG_1351 was established by cross-complementation in the MSMEG_1351 knock-out mutant and also in a DeltapcaA strain of Mycobacterium bovis BCG. Overexpression of MSMEG_1351 restored the wild-type mycolic acid profile and the cording phenotype in BCG. Although the biological significance of mycolic acid cyclopropanation in nonpathogenic mycobacteria remains unclear, it likely represents a mechanism of adaptation of cell wall structure and composition to cope with environmental factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20457615      PMCID: PMC2898377          DOI: 10.1074/jbc.M110.125724

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Mycolic acid structure determines the fluidity of the mycobacterial cell wall.

Authors:  J Liu; C E Barry; G S Besra; H Nikaido
Journal:  J Biol Chem       Date:  1996-11-22       Impact factor: 5.157

Review 2.  Drug sensitivity and environmental adaptation of mycobacterial cell wall components.

Authors:  C E Barry; K Mdluli
Journal:  Trends Microbiol       Date:  1996-07       Impact factor: 17.079

Review 3.  The envelope layers of mycobacteria with reference to their pathogenicity.

Authors:  M Daffé; P Draper
Journal:  Adv Microb Physiol       Date:  1998       Impact factor: 3.517

4.  Separation of C50--60 and C70--80 mycolic acid molecular species and their changes by growth temperatures in Mycobacterium phlei.

Authors:  S Toriyama; I Yano; M Masui; M Kusunose; E Kusunose
Journal:  FEBS Lett       Date:  1978-11-01       Impact factor: 4.124

5.  A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis.

Authors:  Y Yuan; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2.

Authors:  K M George; Y Yuan; D R Sherman; C E Barry
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

Review 7.  The envelope of mycobacteria.

Authors:  P J Brennan; H Nikaido
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

8.  Thermally adaptive changes of mycolic acids in Mycobacterium smegmatis.

Authors:  T Baba; K Kaneda; E Kusunose; M Kusunose; I Yano
Journal:  J Biochem       Date:  1989-07       Impact factor: 3.387

9.  Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis.

Authors:  Y Yuan; R E Lee; G S Besra; J T Belisle; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

10.  Regulation of cell wall mycolic acid biosynthesis in acid-fast bacteria. I. Temperature-induced changes in mycolic acid molecular species and related compounds in Mycobacterium phlei.

Authors:  S Toriyama; I Yano; M Masui; E Kusunose; M Kusunose; N Akimori
Journal:  J Biochem       Date:  1980-07       Impact factor: 3.387

View more
  9 in total

1.  Growth of Mycobacterium tuberculosis biofilms.

Authors:  Kathleen Kulka; Graham Hatfull; Anil K Ojha
Journal:  J Vis Exp       Date:  2012-02-15       Impact factor: 1.355

2.  Phosphorylation of mycobacterial PcaA inhibits mycolic acid cyclopropanation: consequences for intracellular survival and for phagosome maturation block.

Authors:  Rosa Milagros Corrales; Virginie Molle; Jade Leiba; Lionel Mourey; Chantal de Chastellier; Laurent Kremer
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

3.  Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice.

Authors:  Daniel Barkan; Dorsaf Hedhli; Han-Guang Yan; Kris Huygen; Michael S Glickman
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

4.  Synthetic arabinomannan glycolipids impede mycobacterial growth, sliding motility and biofilm structure.

Authors:  Kirtimaan Syal; Krishnagopal Maiti; Kottari Naresh; Prakash Gouda Avaji; Dipankar Chatterji; Narayanaswamy Jayaraman
Journal:  Glycoconj J       Date:  2016-06-04       Impact factor: 2.916

5.  Impact of the epoxide hydrolase EphD on the metabolism of mycolic acids in mycobacteria.

Authors:  Jan Madacki; Françoise Laval; Anna Grzegorzewicz; Anne Lemassu; Monika Záhorszká; Michael Arand; Michael McNeil; Mamadou Daffé; Mary Jackson; Marie-Antoinette Lanéelle; Jana Korduláková
Journal:  J Biol Chem       Date:  2018-02-22       Impact factor: 5.157

Review 6.  Insights into the molecular determinants involved in Mycobacterium tuberculosis persistence and their therapeutic implications.

Authors:  Hemant Joshi; Divya Kandari; Rakesh Bhatnagar
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

7.  Rv0132c of Mycobacterium tuberculosis encodes a coenzyme F420-dependent hydroxymycolic acid dehydrogenase.

Authors:  Endang Purwantini; Biswarup Mukhopadhyay
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

8.  Mycobacterium tuberculosis AtsG (Rv0296c), GlmU (Rv1018c) and SahH (Rv3248c) Proteins Function as the Human IL-8-Binding Effectors and Contribute to Pathogen Entry into Human Neutrophils.

Authors:  Bozena Dziadek; Anna Brzostek; Marcin Grzybowski; Marek Fol; Agnieszka Krupa; Jakub Kryczka; Przemyslaw Plocinski; Anna Kurdowska; Jaroslaw Dziadek
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

9.  The Non-Essential Mycolic Acid Biosynthesis Genes hadA and hadC Contribute to the Physiology and Fitness of Mycobacterium smegmatis.

Authors:  Stevie Jamet; Nawel Slama; Joana Domingues; Françoise Laval; Pauline Texier; Nathalie Eynard; Annaik Quémard; Antonio Peixoto; Anne Lemassu; Mamadou Daffé; Kaymeuang Cam
Journal:  PLoS One       Date:  2015-12-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.